Prognostic Indicators After Surgery for Thymoma

Annals of Thoracic Surgery

Volumn 89, Issue 4, 2010, Pages 1071-1079

  Okereke, Ikenna C ^a   Kesler, Kenneth A ^a   Morad, Mohamed H ^a   Mi, Deming ^a   Rieger, Karen M ^a   Birdas, Thomas J ^a   Badve, Sunil ^a   Henley, John D ^b   Turrentine, Mark W ^a   Nelson, Robert P ^a   Loehrer, Patrick J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pain Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; STERNOTOMY; THORACOTOMY; THYMECTOMY; THYMOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 77949553621     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.01.026     Document Type: Article

References (24)

1. Block M.I. Thymoma. In: Person F., Cooper J., Deslauriers J., et al. (Eds). Thoracic surgery. 2nd ed. 63 (2002), Churchill Livingston, Philadelphia 1688-1696
2. Rosai J., and Sobin L.H. Histologic typing of tumors of the thymus. World Health Organization. International histological classification of tumours (1999), Springer-Verlag, Heidelberg
3. Kim E.S., Putnam J.B., Komaki R., et al. Phase II study of a multidisciplinary approach with induction chemotherapy followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas; final report. Lung Cancer 44 (2004) 369-379
4. Venuta F., Rendina E.A., Longo R., et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 (2003) 1866-1872
5. Wright C.D., Choi N.C., Wain J.C., Mathisen D.J., Lynch T.J., and Fidias P. Chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IV-A thymic tumors. Ann Thorac Surg 85 (2008) 385-389
6. Loehrer Sr. P.J., Kim K., Aisner S.C., et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol 12 (1994) 1164-1168
7. Engles E.A., and Pfeiffer R.M. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignances. Int J Cancer 105 (2003) 546-551
8. Lemma G.L., Loehrer P.J., Lee J.W., Langer C.J., Tester W.J., and Johnson D.H. A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: EC199. J Clin Oncol 20 suppl (2008) 8018 [Abstract]
9. Lee E.K., Maselli R.A., Ellis W.G., and Agius M.A. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. Neurol Neurosurg Psychiatry 65 (1998) 857-862
10. Detterbeck F.C., and Parsons A.M. Thymic tumors. Ann Thorac Surg 77 (2004) 1860-1869
11. Kondo K., and Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg 79 (2005) 219-224
12. Welsh J.S., Wilkins K.B., Green R., et al. Association between thymoma and second neoplasms. JAMA 283 (2000) 1142-1143
13. Suster S. Diagnosis of thymoma. J Clin Pathol 59 (2006) 1238-1244
14. Wright C.D., Wain J.C., Wong D.R., et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
15. Rieker R.J., Hoegel J., Horresi-Hauf A., et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 98 (2002) 900-906
16. Okumura M., Ohta M., Tateyama H., et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
17. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymoma with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
18. Koga K., Matsuno Y., Noguchi M., et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44 (1994) 359-367
19. Gupta R., Marchevsky A.M., McKenna R.J., et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 132 (2008) 926-930
20. Macchiarini P., Chella A., Ducci F., et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68 (1991) 706-713
21. Lucchi M., Melfi F., Dini P., et al. Neoadjuvant chemotherapy for stage III and IV-A thymoma; a single institution experience with long term follow-up. J Thorac Oncol 1 (2006) 308-313
22. Wright C.D. Pleuropneumonectomy for thymoma. Ann Thorac Surg 82 (2006) 1234-1239
23. Huang J., Rizk N.P., Travis W.D., et al. Feasibility of multimodality therapy including extended resection in stage IV-A thymoma. J Thorac Cardiovasc Surg 134 (2007) 1477-1484
24. Ishikawa Y., Matsuguma H., Nakahara R., et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: The potential role of extrapleural pneumonectomy. Ann Thorac Surg 88 (2009) 952-957